These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26523837)

  • 21. Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIs.
    Lee SJ; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Lung Cancer; 2015 Nov; 90(2):261-6. PubMed ID: 26371700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
    Luo Y; Teng Z; Li Y; Wang Q
    Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
    Grenha A; Remuñán-López C; Carvalho EL; Seijo B
    Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line.
    Abd-Rabou AA; Ahmed HH
    Adv Med Sci; 2017 Sep; 62(2):357-367. PubMed ID: 28521254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.
    Nascimento AV; Gattacceca F; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Nanomedicine (Lond); 2016 Apr; 11(7):767-81. PubMed ID: 26980454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembled polymeric nanoparticle of PEGylated chitosan-ceramide conjugate for systemic delivery of paclitaxel.
    Battogtokh G; Ko YT
    J Drug Target; 2014 Nov; 22(9):813-21. PubMed ID: 24964055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
    Campos J; Varas-Godoy M; Haidar ZS
    Nanomedicine (Lond); 2017 Mar; 12(5):473-490. PubMed ID: 28181464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
    Karra N; Nassar T; Ripin AN; Schwob O; Borlak J; Benita S
    Small; 2013 Dec; 9(24):4221-36. PubMed ID: 23873835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
    Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
    Islam N; Ferro V
    Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells.
    Maya S; Kumar LG; Sarmento B; Sanoj Rejinold N; Menon D; Nair SV; Jayakumar R
    Carbohydr Polym; 2013 Apr; 93(2):661-9. PubMed ID: 23499109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted delivery of low molecular drugs using chitosan and its derivatives.
    Park JH; Saravanakumar G; Kim K; Kwon IC
    Adv Drug Deliv Rev; 2010 Jan; 62(1):28-41. PubMed ID: 19874862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
    Liu CW; Lin WJ
    J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
    Tomasina J; Poulain L; Abeilard E; Giffard F; Brotin E; Carduner L; Carreiras F; Gauduchon P; Rault S; Malzert-Fréon A
    Int J Pharm; 2013 Dec; 458(1):197-207. PubMed ID: 24084450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: In vitro and in vivo evaluation.
    Wang J; Su G; Yin X; Luo J; Gu R; Wang S; Feng J; Chen B
    Biomed Pharmacother; 2019 Dec; 120():109493. PubMed ID: 31586902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
    Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
    Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.